4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-20-010450
Chairman & CEO sold 251,572 shares at an average $21.02 ($5,288,013)
- Chairman & CEO acquired 151,572 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Patel Sanj K · Chairman & CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-09 | Exercise or conversion : show line 1 in the form | +872 | $1.59 | $1,386 | 872 | D |
| 2020-10-09 | Sale : show line 2 in the form | −872 | $21.00 | $18,312 | 0 | D |
| 2020-10-09 | Sale : show line 3 in the form | −670 | $21.00 | $14,070 | 211,900 | I |
| 2020-10-12 | Exercise or conversion : show line 4 in the form | +150,700 | $1.59 | $239,613 | 150,700 | D |
| 2020-10-12 | Sale : show line 5 in the form | −150,700 | $21.02 | $3,167,714 | 0 | D |
| 2020-10-12 | Sale : show line 6 in the form | −99,330 | $21.02 | $2,087,917 | 112,570 | I |
| Open-market sales · 251,572 sh · avg $21.02 · $5,288,013 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-09 | Exercise or conversion : show line 7 in the form Share Option | −872 | 502,896 | D |
| 2020-10-12 | Exercise or conversion : show line 8 in the form Share Option | −150,700 | 352,196 | D |
Loading xslF345X03/edgar.xml…